Truvian Sciences: Raises More Than $105M in Series C Financing USA

  • Truvian Sciences, a San Diego, CA-based closed more than $105m in a Series C financing
  • The round, which brought total funding to more than $150m to date, led by TYH Ventures, Glen Tullman of 7wireVentures, and Wittington Ventures
  • Truvian is a healthcare company at the intersection of diagnostics and consumer technology
  • Its automated benchtop system developed to produce lab-accurate results for a full-suite of health tests using a small sample of blood
  • The company also announced a roster of executive and board appointments
  • Former Divisional VP of Automation and Informatics at Abbott, Jay Srinivasan, has joined the company as Chief Product Officer
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Swedish Court Delays Judgment in Klarna’s Antitrust Case Against Google

The court's decision is crucial for Klarna's operations in the competitive market.Highlights: Swedish court delays decision on Klarna's...

Morgan Stanley Launches Bitcoin ETF, Expanding Crypto Offerings

The investment firm broadens its reach into the cryptocurrency market.Highlights: Morgan Stanley launches a Bitcoin ETF to enhance...

HSBC Strengthens Position with Hong Kong Stablecoin Issuer License

The banking giant aims to support digital asset initiatives in the region.Highlights: HSBC receives a stablecoin issuer license...

US Treasury Secretary Warns Banks About Anthropic’s New AI Model

Treasury Secretary highlights risks AI poses to financial stability.Highlights: US Treasury Secretary warns banks about the risks of...